Translational cancer research for tomorrow´s targeted therapy: the barometer of VHIO success

In a joint ecancermedicalscience interview filmed at ASCO 2011 in Chicago, José Baselga and Josep Tabernero describe the early beginnings of the Vall d´Hebron Institute of Oncology (VHIO), milestones since marked thanks to its translational, multidisciplinary and combined approach to cancer research, how other institutes can replicate such efforts, some Boston-Barcelona synergies, and horizons ahead upon the forthcoming construction of VHIO´s next home.

Designed to centralize all VHIO´s research programs and core technologies in the same physical space, this new building – the Cellex Building, will further promote the interconnectivity and cross-talk between oncology specialists en force in order to carry out translational research even more rapidly and dynamically.

To access this interview and find out more click here.

Related Posts

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.